Your browser doesn't support javascript.
loading
Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants.
Eap, C B; Gründer, G; Baumann, P; Ansermot, N; Conca, A; Corruble, E; Crettol, S; Dahl, M L; de Leon, J; Greiner, C; Howes, O; Kim, E; Lanzenberger, R; Meyer, J H; Moessner, R; Mulder, H; Müller, D J; Reis, M; Riederer, P; Ruhe, H G; Spigset, O; Spina, E; Stegman, B; Steimer, W; Stingl, J; Suzen, S; Uchida, H; Unterecker, S; Vandenberghe, F; Hiemke, C.
Afiliação
  • Eap CB; Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neurosciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Gründer G; Center for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Baumann P; School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.
  • Ansermot N; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.
  • Conca A; Institute of Pharmaceutical Sciences of Western Switzerland, University of Lausanne, Switzerland, Geneva, Switzerland.
  • Corruble E; Department of Molecular Neuroimaging, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Crettol S; Department of Psychiatry, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Dahl ML; Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neurosciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • de Leon J; Department of Psychiatry, Health Service District Bolzano, Bolzano, Italy.
  • Greiner C; Department of Child and Adolescent Psychiatry, South Tyrolean Regional Health Service, Bolzano, Italy.
  • Howes O; INSERM CESP, Team ≪MOODS≫, Service Hospitalo-Universitaire de Psychiatrie, Universite Paris Saclay, Le Kremlin Bicetre, France.
  • Kim E; Service Hospitalo-Universitaire de Psychiatrie, Hôpital Bicêtre, Assistance Publique Hôpitaux de Paris, Le Kremlin Bicêtre, France.
  • Lanzenberger R; Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neurosciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Meyer JH; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Moessner R; Eastern State Hospital, University of Kentucky Mental Health Research Center, Lexington, KY, USA.
  • Mulder H; Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn, Germany.
  • Müller DJ; King's College London and MRC London Institute of Medical Sciences (LMS)-Imperial College, London, UK.
  • Reis M; Department of Brain and Cognitive Sciences, Seoul National University College of Natural Sciences, Seoul, South Korea.
  • Riederer P; Department of Psychiatry, Seoul National University College of Medicine, Seoul, South Korea.
  • Ruhe HG; Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
  • Spigset O; Campbell Family Mental Health Research Institute, CAMH and Department of Psychiatry, University of Toronto, Toronto, Canada.
  • Spina E; Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany.
  • Stegman B; Department of Clinical Pharmacy, Wilhelmina Hospital Assen, Assen, The Netherlands.
  • Steimer W; GGZ Drenthe Mental Health Services Drenthe, Assen, The Netherlands.
  • Stingl J; Department of Pharmacotherapy, Epidemiology and Economics, Department of Pharmacy and Pharmaceutical Sciences, University of Groningen, Groningen, The Netherlands.
  • Suzen S; Department of Psychiatry, Interdisciplinary Centre for Psychopathology and Emotion Regulation, University of Groningen, Groningen, The Netherlands.
  • Uchida H; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Unterecker S; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Vandenberghe F; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.
  • Hiemke C; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
World J Biol Psychiatry ; 22(8): 561-628, 2021 10.
Article em En | MEDLINE | ID: mdl-33977870
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Farmacogenética / Psiquiatria Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Farmacogenética / Psiquiatria Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article